Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sitkei

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Orvosi Hetilap|January 1, 1984
[Digitalis sensitivity in chronic obstructive lung disease]L Perger, E Sitkei, L Matos, et al.
Cardiovascular Surgery (London, England)|December 1, 1996
Surgical removal from the descending aorta of a floating thrombus caused by blunt chest traumaL Lukács, M Lengyel, E Sitkei, et al.
Orvosi Hetilap|July 26, 1987
[Pacemaker implantation in atrioventricular block, a manifestation of Kearns-Sayre syndrome]A Temesvári, E Sitkei, A Szatmári, et al.
Orvosi Hetilap|September 15, 1991
[Thrombolysis by tissue plasminogen activator in acute myocardial infarct]M Keltai, P Dékány, J Németh, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Orvosi Hetilap|January 1, 1984
[Digitalis sensitivity in chronic obstructive lung disease]L Perger, E Sitkei, L Matos, et al.
Cardiovascular Surgery (London, England)|December 1, 1996
Surgical removal from the descending aorta of a floating thrombus caused by blunt chest traumaL Lukács, M Lengyel, E Sitkei, et al.
Orvosi Hetilap|July 26, 1987
[Pacemaker implantation in atrioventricular block, a manifestation of Kearns-Sayre syndrome]A Temesvári, E Sitkei, A Szatmári, et al.
Orvosi Hetilap|September 15, 1991
[Thrombolysis by tissue plasminogen activator in acute myocardial infarct]M Keltai, P Dékány, J Németh, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
Pageof 1